Stock Traders Purchase Large Volume of Teladoc Health Call Options (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) was the recipient of some unusual options trading on Tuesday. Traders bought 22,980 call options on the stock. This represents an increase of 69% compared to the average daily volume of 13,593 call options.

Teladoc Health Stock Up 0.5 %

Shares of TDOC traded up $0.05 during mid-day trading on Tuesday, reaching $9.98. The company's stock had a trading volume of 4,485,137 shares, compared to its average volume of 3,704,496. The stock has a market cap of $1.72 billion, a PE ratio of -1.73 and a beta of 1.01. Teladoc Health has a 12-month low of $6.76 and a 12-month high of $22.16. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The company's 50 day moving average is $9.92 and its 200 day moving average is $9.03.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The company had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million. Equities analysts anticipate that Teladoc Health will post -1.16 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently commented on TDOC shares. Piper Sandler restated an "overweight" rating and issued a $13.00 price objective (up from $11.00) on shares of Teladoc Health in a research report on Wednesday, December 4th. The Goldman Sachs Group initiated coverage on Teladoc Health in a research note on Friday, November 15th. They issued a "buy" rating and a $14.00 target price for the company. Barclays boosted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company an "overweight" rating in a research report on Thursday, October 31st. Royal Bank of Canada increased their target price on Teladoc Health from $9.00 to $10.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 9th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Teladoc Health from $10.00 to $12.00 and gave the stock a "hold" rating in a research note on Friday, November 1st. Fourteen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $12.24.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the firm's stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the transaction, the insider now directly owns 2,890 shares of the company's stock, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.95% of the company's stock.

Institutional Trading of Teladoc Health

Several institutional investors and hedge funds have recently modified their holdings of the business. Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of Teladoc Health by 15.5% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider's stock valued at $15,617,000 after buying an additional 228,004 shares during the period. Clearline Capital LP raised its position in Teladoc Health by 395.6% in the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider's stock valued at $42,682,000 after purchasing an additional 3,483,665 shares during the period. The Manufacturers Life Insurance Company lifted its stake in shares of Teladoc Health by 195.3% during the second quarter. The Manufacturers Life Insurance Company now owns 95,307 shares of the health services provider's stock worth $932,000 after purchasing an additional 63,028 shares in the last quarter. Jennison Associates LLC purchased a new stake in shares of Teladoc Health in the third quarter worth about $1,544,000. Finally, Massachusetts Financial Services Co. MA boosted its position in shares of Teladoc Health by 477.1% in the third quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider's stock worth $3,397,000 after buying an additional 305,961 shares during the period. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.